Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and Trem2
Journal of Experimental Medicine · 04.03.2024 · 221 (3)
DOI: 10.1084/jem.20231011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 30.01.2024. Verfasst von Chen Yu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Duke University School of Medicine, Durham, NC, USA. Hauptthemen laut MEDLINE: Galectin 3, Membrane Glycoproteins, Receptors, Immunologic, Retinal Degeneration. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: NEI NIH HHS, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Outer retinal degenerations, including age-related macular degeneration (AMD), are characterized by photoreceptor and retinal pigment epithelium (RPE) atrophy. In these blinding diseases, macrophages accumulate at atrophic sites, but their ontogeny and niche specialization remain poorly understood, especially in humans. We uncovered a unique profile of microglia, marked by galectin-3 upregulation, at atrophic sites in mouse models of retinal degeneration and human AMD. In disease models, conditional deletion of galectin-3 in microglia led to phagocytosis defects and consequent augmented photoreceptor death, RPE damage, and vision loss, indicating protective roles. Mechanistically, Trem2 signaling orchestrated microglial migration to atrophic sites and induced galectin-3 expression. Moreover, pharmacologic Trem2 agonization led to heightened protection but in a galectin-3–dependent manner. In elderly human subjects, we identified this highly conserved microglial population that expressed galectin-3 and Trem2. This population was significantly enriched in the macular RPE-choroid of AMD subjects. Collectively, our findings reveal a neuroprotective population of microglia and a potential therapeutic target for mitigating retinal degeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Duke University School of Medicine, Durham, NC, USA.
- Department of Immunology, Duke University, Durham, NC, USA.
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
- German Center for Neurodegenerative Diseases Munich , Munich, Germany.
- Department of Cell Biology, Duke University, Durham, NC, USA.
ORCID-Profile: Chen Yu, Eleonora M Lad, Rose Mathew, Nobuhiko Shiraki, Sejiro Littleton, Yun Chen, Jinchao Hou, Kai Schlepckow, Simone Degan, Lindsey Chew, Joshua Amason, Joan Kalnitsky, Catherine Bowes Rickman, Alan D Proia, Marco Colonna, Christian Haass, Daniel R Saban
Förderung
- NEI NIH HHS
- NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- National Eye Institute
- BrightFocus Foundation
- Research to Prevent Blindness
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Yu, C., Lad, E. M., Mathew, R., Shiraki, N., Littleton, S., Chen, Y., Hou, J., Schlepckow, K., Degan, S., Chew, L., Amason, J., Kalnitsky, J., Bowes Rickman, C., Proia, A. D., Colonna, M., Haass, C., & Saban, D. R. (2024). Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and Trem2. Journal of Experimental Medicine, 221(3). https://doi.org/10.1084/jem.20231011
Vancouver
Yu C, Lad EM, Mathew R, Shiraki N, Littleton S, Chen Y, et al. Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and Trem2. Journal of Experimental Medicine. 2024;221(3). doi:10.1084/jem.20231011
BibTeX
@article{Yu2024,
author = {Yu, Chen and Lad, Eleonora M and Mathew, Rose and Shiraki, Nobuhiko and Littleton, Sejiro and Chen, Yun and Hou, Jinchao and Schlepckow, Kai and Degan, Simone and Chew, Lindsey and Amason, Joshua and Kalnitsky, Joan and Bowes Rickman, Catherine and Proia, Alan D and Colonna, Marco and Haass, Christian and Saban, Daniel R},
title = {Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and Trem2},
journal = {Journal of Experimental Medicine},
year = {2024},
volume = {221},
number = {3},
doi = {10.1084/jem.20231011}
}
EUVIMED